BIOMAT Database Logo BIOMAT Database Logo

[Pathologic phenotypes of alpha 1-protease inhibitor in patients with pulmonary tuberculosis]. 1991

T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000511 alpha-Macroglobulins Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters. Slow alpha 2-Macroglobulins,alpha 2-Acute Phase Globulins,alpha-Macrofetoproteins,45S RNP,Acute-Phase alpha 1-Protein,Slow alpha 2-Globulin,alpha 1-Acute Phase Globulin,alpha 1-Acute Phase Protein,alpha 1-Macroglobulin,alpha 2-Acute Phase Globulin,alpha-Macrofetoprotein,Acute Phase alpha 1 Protein,RNP, 45S,Slow alpha 2 Globulin,Slow alpha 2 Macroglobulins,alpha 1 Acute Phase Globulin,alpha 1 Acute Phase Protein,alpha 1 Macroglobulin,alpha 1-Protein, Acute-Phase,alpha 2 Acute Phase Globulin,alpha 2 Acute Phase Globulins,alpha 2-Globulin, Slow,alpha 2-Macroglobulins, Slow,alpha Macrofetoprotein,alpha Macrofetoproteins,alpha Macroglobulins
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises
D019896 alpha 1-Antitrypsin Deficiency Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS. Deficiencies, alpha 1-Antitrypsin,Deficiency, alpha 1-Antitrypsin,alpha 1 Antitrypsin Deficiency,alpha 1-Antitrypsin Deficiencies

Related Publications

T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
Alpha-1-protease inhibitor phenotypes in Australia.
January 1982, Human heredity,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
Alpha-1-antitrypsin (protease inhibitor) phenotypes and longevity.
January 1990, Human heredity,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes.
April 1993, Clinical chemistry,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
alpha-1-Protease inhibitor phenotypes and serum concentrations in Thailand.
January 1980, Human genetics,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
Protease inhibitor phenotypes and pulmonary disease in patients with Sjögren's syndrome.
January 1981, Respiration; international review of thoracic diseases,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics.
June 1992, The American review of respiratory disease,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
Alpha-1-antitrypsin protease inhibitor (Pi) phenotypes in Down's syndrome patients and their parents.
January 1982, Clinical genetics,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
alpha(1)-Protease Inhibitor Deficiency and Pulmonary Emphysema.
May 1988, The Western journal of medicine,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
[Pulmonary veno-arterial alpha 1 protease inhibitor differences in patients with chronic lung disease].
January 1988, Nihon Kyobu Shikkan Gakkai zasshi,
T A Muminov, and S M Medvedskiĭ, and T D Talbaev, and L A Il'chenko, and A T Sharmanov
Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor.
March 2001, Chest,
Copied contents to your clipboard!